Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novavax Inc
(NQ:
NVAX
)
8.940
+0.640 (+7.71%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novavax Inc
< Previous
1
2
3
4
5
6
7
8
9
...
60
61
Next >
Deal Dispatch: Ubisoft In Buyout Talks, Dental Supplier Explores Sale, Beloved Drive-Through Goes Bankrupt
December 07, 2024
Dental supply maker Patterson Companies Inc announced Thursday that it is exploring strategic options, including a sale or merger, to boost shareholder value.
Via
Benzinga
Topics
Supply Chain
Exposures
Supply Chain
2 Beaten-Down "Pandemic Stocks" to Consider for Contrarian Investors
December 05, 2024
Via
The Motley Fool
Wegovy Maker Novo Nordisk To Buy Novavax's Czech Republic Manufacturing Facility For $200 Million
December 04, 2024
Novavax sells Czech manufacturing facility to Novo Nordisk for $200 million, aiming to cut costs by $80 million annually and support its growth strategy.
Via
Benzinga
Is Biotech’s Bull Run Over? Examining Election Impacts
November 21, 2024
The biotech sector's breakout attempt post-election reversed sharply, with ETFs like IBB and XBI falling and invalidating the long-term bullish setup.
Via
MarketBeat
Topics
ETFs
Government
Exposures
Political
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
Earnings Outlook For Novavax
November 11, 2024
Via
Benzinga
Looking Into Novavax's Recent Short Interest
November 11, 2024
Via
Benzinga
How Is The Market Feeling About Novavax?
November 06, 2024
Via
Benzinga
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
November 15, 2024
To gain an edge, this is what you need to know today.
Via
Benzinga
Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS
November 15, 2024
President-elect Donald Trump tapped widely known vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
Via
Investor's Business Daily
Topics
Government
Exposures
Political
WHO Calls Vaccines 'Absolutely Critical' As Trump's Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill
November 15, 2024
Trump's decision to appoint Kennedy, known for his vaccine skepticism, has sparked significant attention.
Via
Benzinga
Topics
Government
Exposures
Political
Here's How Much $1000 Invested In Novavax 5 Years Ago Would Be Worth Today
October 02, 2024
Via
Benzinga
US Stocks Likely To Open In Red After Jerome Powell Says No Need To Be 'In A Hurry' On Rate Cuts: Tesla, TSMC And Domino's In Focus
November 15, 2024
U.S. stocks could open on a negative note on Friday after the Federal Reserve chair Jerome Powell's comments on Thursday that the economy is showing enough strength that there is no need to be "in a...
Via
Benzinga
Topics
Economy
Exposures
Economy
Interest Rates
Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower
November 14, 2024
Trump may appoint Robert F. Kennedy Jr. as HHS Secretary, stirring mixed reactions. Kennedy's views on vaccines could reshape policies and affect vaccine stocks.
Via
Benzinga
Topics
Government
Exposures
Political
Novavax Lowers 2024 Forecast Despite Q3 Revenue Beat, Stock Falls
November 12, 2024
Novavax reports Q3 2024 sales of $84.5 million, beating estimates, with a net loss of $121 million. EPS improves, FDA approves new vaccine, and revenue guidance is lowered.
Via
Benzinga
Exposures
Product Safety
FDA Gives Green Signal To Novavax's COVID-19-Influenza Combo Vaccine Late-Stage Trial
November 11, 2024
FDA lifts clinical hold on Novavax's COVID-19-influenza combo vaccine, clearing path for Phase 3 trials. Novavax to resume trial activities soon.
Via
Benzinga
Exposures
Product Safety
Smaller Cap Biotechs Are In Season: How Are We Doing?
November 07, 2024
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range.
Via
Talk Markets
Why Is COVID-19 Vaccine Maker Novavax Stock Trading Lower On Wednesday?
November 06, 2024
Novavax ends UK COVID-19 vaccine contract, agreeing to repay $123.8M in quarterly installments by 2027 as part of settlement.
Via
Benzinga
Exposures
COVID-19
NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Novavax, Inc. and Encourages Investors to Contact the Firm
October 28, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
3 Spooky Signs That You're About to Lose Your Money on a Healthcare Stock Investment
October 26, 2024
Knowing these will help you avoid making suboptimal investing decisions.
Via
The Motley Fool
This Vaccine Stock Just Dropped by 20%: Should You Buy the Dip?
October 21, 2024
Let's look beyond this piece of bad news from regulators.
Via
The Motley Fool
NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Novavax, Inc. and Encourages Investors to Contact the Firm
October 20, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
How Bad Is This News for Novavax?
October 19, 2024
Novavax stock fell 20% in one trading session on the news.
Via
The Motley Fool
Robinhood, Novavax, Phunware, Lucid Group, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
October 16, 2024
On Wednesday, major U.S. indices saw gains, with the Dow Jones Industrial Average climbing nearly 0.8% to 43,077.70.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Nasdaq Moves Higher; Morgan Stanley Profit Beats Estimates
October 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 16, 2024
Via
Benzinga
Dow Jumps 250 Points; U.S. Bancorp Earnings Top Views
October 16, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
FDA Puts Speed Breaker On Novavax's COVID/Flu Combo Shot Trial On Concerns Related To Damaged Nerves
October 16, 2024
Novavax stock dips as the FDA pauses its COVID-19-influenza vaccine trials following a serious adverse event.
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 16, 2024
Via
Benzinga
What's Going On With Novavax Stock Today?
October 09, 2024
Novavax Inc (NASDAQ:NVAX) shares are bouncing around Wednesday, pulling back after popping in early trading. The company announced that it received European marketing authorization for its Nuvaxovid...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
3
4
5
6
7
8
9
...
60
61
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.